Bliss GVS
- Product NDC
- 72701-105
- 11-digit product format
- 727010105
- Labeler code
- 72701
- Product ID
- 72701-105_24aa2d9b-97e2-780c-e063-6394a90aa591
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Glycerin
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Bliss GVS Pharma Limited
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-01-20
- Substance
- GLYCERIN
- Active strength
- 1.2 g/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 72701-105-25 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 72701-105-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 72701-105-25 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 72701-105-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 72701-105-25 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 72701-105-12 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 72701-105-25 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 72701-105-12 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 72701-105-25 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 72701-105-12 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bliss GVS
- Brand name suffix
- Children
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCERIN | 1.2 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| PDC6A3C0OX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 421299 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 03237ed2-265f-4acd-b504-d82b9263287c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3c386306-c48a-413e-bb69-70cb268496f3 | Product name | 1 | 20210727 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 72701-105-12 | 2024-10-17 | Bliss Glycerin Suppositories, Children |
| 72701-105-25 | 2024-10-17 | Bliss Glycerin Suppositories, Children |
| 72701-105-12 | 2024-01-30 | Bliss Glycerin Suppositories, Children |
| 72701-105-25 | 2024-01-30 | Bliss Glycerin Suppositories, Children |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72701-105-12 | Bliss GVSChildren | 2 in 1 CARTON | SUPPOSITORY | 2 | 2 | |
| 72701-105-12 | Bliss GVSChildren | 6 in 1 BLISTER PACK | SUPPOSITORY | 6 | 2 | |
| 72701-105-25 | Bliss GVSChildren | 5 in 1 BLISTER PACK | SUPPOSITORY | 5 | 2 | |
| 72701-105-25 | Bliss GVSChildren | 5 in 1 CARTON | SUPPOSITORY | 5 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NuValu Epsom Salt | MAGNESIUM SULFATE (HEPTAHYDRATE) | J C SALES | 5a503d8d-7899-4b1e-be6f-8e2a759af265 | 2024-12-04 | Warnings | M007 |
| SENNOSIDES | SENNOSIDES | CVS Pharmacy, Inc. | 6dffc3f5-bae0-c436-e053-2991aa0a0f8b | 2024-12-02 | Warnings | M007 |
| Pure and Gentle | MINERAL OIL | Medline Industries, LP | 96d4cad5-0602-4c31-94ed-3117b4fd4a94 | 2024-11-26 | Warnings | M007 |
| Pure and Gentle Laxative | SODIUM PHOSPHATE | Medline Industries, LP | e3165538-75dd-4f0f-adc8-d4075de10f1e | 2024-11-26 | Warnings | M007 |
| DOCUSATE SODIUM 50 MG | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | af7533e6-8b06-48a4-940e-7ecb57b24b59 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | a923e5ca-86fd-4bf9-9931-180ddfdeae66 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. | 7cf1df18-d658-4bff-8a62-365fc5656942 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM 100mg | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. | c5bdfbfc-d24a-4088-9b60-ecea8120ff43 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | b10fdf50-289e-41f3-9b83-a4e4dd892f88 | 2024-11-21 | Warnings | M007 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | 85c64624-428d-46fa-8071-f42b8feec049 | 2024-11-21 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd | 33251cb7-b7b1-4f6c-9e10-4fa64cbf03a0 | 2024-11-21 | Warnings | M007 |
| STOOL SOFTENER | DOCUSATE SODIUM | Walgreen Co. | d8d97ca5-5131-4620-8ce9-bc3f9d5c0ab5 | 2024-11-21 | Warnings | M007 |
| 4718 Enema, Mineral Oil | 4718 ENEMA, MINERAL OIL | Dynarex | 9e51c852-9477-5cf5-e053-2a95a90a97db | 2024-11-20 | Warnings | M007 |
| Relief | SODIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Leosons Overseas Corp | 5b301d5b-1e2c-47ed-a05f-d6be0fdfc940 | 2024-11-19 | Warnings | M007 |
| REFLIEF SALINE LAXATIVE PEDIATRIC READY TO USE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Leosons Overseas Corp | 90e7c2b4-35e1-4a27-afea-9257c480e190 | 2024-11-19 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM 100MG | PuraCap Pharmaceutical LLC | 272c86f1-f229-2ebf-e063-6394a90a3471 | 2024-11-18 | Warnings | M007 |
| Milk of Magnesia Concentrate | MAGNESIUM HYDROXIDE | PAI Holdings, LLC dba PAI Pharma | 2a99a1a8-a830-429f-9cfd-3f29c3d3547c | 2024-11-12 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | A-S Medication Solutions | 122486e9-74dd-4181-97d1-0b07688280f4 | 2024-11-06 | Warnings | M007 |
| Stratuscare Adult Glycerin | GLYCERIN | Stratus Pharmaceuticals | 3e1935da-5c1f-4942-98dd-320fade82321 | 2024-11-04 | Warnings | M007 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | NuCare Pharmaceuticals,Inc. | fdf3c8e1-d554-4cdb-e053-6394a90a542e | 2024-11-01 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 421299 | glycerin 1.2 GM Pediatric Rectal Suppository | PSN | 03237ed2-265f-4acd-b504-d82b9263287c | 2 |
| 421299 | glycerin 1200 MG Rectal Suppository | SCD | 03237ed2-265f-4acd-b504-d82b9263287c | 2 |
| 421299 | glycerin 1.2 GM Rectal Suppository | SY | 03237ed2-265f-4acd-b504-d82b9263287c | 2 |
| 421299 | glycerin 82.5 % Pediatric Rectal Suppository | SY | 03237ed2-265f-4acd-b504-d82b9263287c | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72701-105-12 | 72701010512 | 2 BLISTER PACK in 1 CARTON (72701-105-12) / 6 SUPPOSITORY in 1 BLISTER PACK | 2 blister pack | 2020-01-20 | 0000-00-00 | No | No | Current |
| 72701-105-25 | 72701010525 | 5 BLISTER PACK in 1 CARTON (72701-105-25) / 5 SUPPOSITORY in 1 BLISTER PACK | 5 blister pack | 2020-01-20 | 0000-00-00 | No | No | Current |